$ Value
$0
Shares
54,934
Price
$0
Filed
Feb 12
Insider
Name
HAZEN SAMUEL N
Title
CEO
CIK
0001216838
Roles
Transaction Details
Transaction Date
2026-02-10
Code
A
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
86,165
Footnotes
On January 30, 2023, the reporting person was granted 27,467 performance share units. The performance share units were eligible to vest based on achievement of a cumulative earnings per share goal for fiscal years 2023-2025. The number of performance share units that were eligible to vest varied from zero (for actual performance less than 90% of target) to two times the units granted (for actual performance of 110% or more of target). Based upon the Company's achievement with respect to cumulative 2023-2025 earnings per share, the number of performance share units that vested equaled 200% of the units granted.
Filing Info
HAZEN SAMUEL N's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-02-10 | HCA | A | $0 |
| 2026-02-10 | HCA | F | $10.7M |
| 2026-02-04 | HCA | J | $521K |
| 2026-02-04 | HCA | J | $521K |
| 2026-02-03 | HCA | ▼ | $7.4M |
| 2026-02-03 | HCA | ▼ | $2.5M |
| 2026-02-03 | HCA | ▼ | $3.7M |
| 2026-02-03 | HCA | ▼ | $3.1M |
| 2026-02-03 | HCA | ▼ | $2.6M |
| 2026-02-03 | HCA | ▼ | $2.1M |
Other Insiders at HCA (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
| FRIST THOMAS F JR | — | — | 2026-02-06 |
|
HAZEN SAMUEL N
CEO
|
— | $21.5M | 2026-02-10 |
| FRIST THOMAS F III | — | — | 2026-02-06 |
| HERCULES HOLDING II | — | — | 2026-02-06 |
| Frisco Holding II | — | — | 2026-02-06 |
| Elcan Patricia F | — | — | 2026-02-06 |
| Frist William R | — | — | 2026-02-06 |
|
Foster Jon M
EVP and COO
|
— | — | 2026-02-10 |
|
Cuffe Michael S.
EVP and Chief Clinical Officer
|
— | $747K | 2026-02-10 |
|
Wyatt Christopher F.
SVP & Controller
|
— | $2.0M | 2026-02-11 |
|
Berres Jennifer
SVP & Chief Human Res. Officer
|
— | $4.1M | 2026-02-11 |
|
McAlevey Michael R
EVP & Chief Legal & Admin Off.
|
— | $904K | 2026-02-18 |
|
Marks Mike A
EVP and CFO
|
— | — | 2026-02-10 |
|
Rossitto Erica
SVP & Chief Nurse Executive
|
— | — | 2026-02-10 |